VitaNova Life Sciences (VNOV) EPS (Weighted Average and Diluted) Growth (1y) (2018 - 2026)
VitaNova Life Sciences (VNOV) EPS (Weighted Average and Diluted) Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
| 1 |
Akso Health |
2,315,158.81 Bn |
2,315,158.63 Bn |
- |
- |
| 2 |
Mckesson |
92.76 Bn |
89.18 Bn |
4.04 Bn |
37.60% |
| 3 |
Cencora |
52.82 Bn |
50.83 Bn |
3.59 Bn |
128.26% |
| 4 |
Cardinal Health |
52.17 Bn |
48.39 Bn |
2.50 Bn |
-19.52% |
| 5 |
Henry Schein |
9.19 Bn |
9.71 Bn |
1.07 Bn |
4.55% |
| 6 |
Accendra Health |
246.88 Mn |
-90.00 Mn |
312.39 Mn |
-60.00% |
| 7 |
Edap Tms |
161.92 Mn |
146.92 Mn |
8.15 Mn |
-20.00% |
| 8 |
111 |
107.47 Mn |
25.61 Mn |
23.58 Mn |
-400.00% |
| 9 |
Cosmos Health |
9.42 Mn |
7.26 Mn |
1.38 Mn |
-100.00% |
| 10 |
VitaNova Life Sciences |
- |
- |
316,343.00 |
-200.00% |
| Date | Value |
|---|
| Jan 31, 2026 |
-200.00% |
| Oct 31, 2025 |
9.69% |
| Jul 31, 2025 |
16.14% |
| Apr 30, 2025 |
100.00% |
| Jan 31, 2025 |
4,105.16% |
| Oct 31, 2024 |
187.53% |
| Jul 31, 2024 |
46.55% |
| Apr 30, 2024 |
1,438.94% |
| Jan 31, 2024 |
105.68% |
| Oct 31, 2023 |
-436.60% |
| Jul 31, 2023 |
-1,236.22% |
| Apr 30, 2023 |
83.64% |
| Jan 31, 2023 |
-375.62% |
| Oct 31, 2022 |
-82.67% |
| Jul 31, 2022 |
-98.50% |
| Apr 30, 2022 |
-4.87% |
| Jul 31, 2018 |
-114.37% |
